JENNIFER WILSON: Open Payments
NPI 1972109254 · SELAH, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,886 in 83 payments from 7 companies in 2025. Trend: 2023 $475 · 2024 $1,370 · 2025 $20,886
Speaker / faculty: $8,251Travel & lodging: $6,259Consulting: $3,561Food & beverage: $2,743Education: $73
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 53 | $20,063 |
| Teva Pharmaceuticals USA, Inc. | 5 | $204 |
| Neurocrine BioSciences, Inc. | 3 | $188 |
| Otsuka America Pharmaceutical, Inc. | 18 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $107 |
| Axsome Therapeutics, Inc. | 1 | $81 |
| Alkermes, Inc. | 2 | $71 |
Products named: COBENFY, INGREZZA, ABILIFY MAINTENA, AUSTEDO XR, CAPLYTA, Auvelity, LYBALVI, ARISTADA.
Industry payments across WA — which companies pay providers there.
